<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>佰傲谷BioValley | wechat-feeds</title><link>http://MzU1NTg4OTM3Mg.favicon.privacyhide.com/favicon.ico</link><description>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 22 Feb 2021 13:14:57 +0800</pubDate><image><url>http://MzU1NTg4OTM3Mg.favicon.privacyhide.com/favicon.ico</url><title>佰傲谷BioValley | wechat-feeds</title><link>http://MzU1NTg4OTM3Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>专访 | 药明生物李竞博士：早期研究质量决定生物药成败</title><link>https://mp.weixin.qq.com/s/keSJx3vRQB_R8tkyFhN4-w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpbWBtxYtD21Zdiaz0sicwf8RMHo8Qic25tw9YdBAcMzTibRHtbNYUiaXzfWGic6bzAwuS64kJY8LXfGm02Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>佰傲谷分享：早期研发质量的合规，决定了产品的成败。]]></content:encoded><pubDate>Mon, 22 Feb 2021 13:03:59 +0800</pubDate></item><item><title>传奇生物2020初步业绩：约2.5亿美元主要用于投资CAR-T产品cilta-cel</title><link>https://mp.weixin.qq.com/s/qCSmeCWv49CJND__WJtp2w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpbWBtxYtD21Zdiaz0sicwf8RM12cmribegEe1gtyKmJKnicBTzFBl21iaT6nfY1njBYlrC7Riaz2V7ZnRsQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Mon, 22 Feb 2021 13:03:59 +0800</pubDate></item><item><title>IL-36：炎症与肿瘤</title><link>https://mp.weixin.qq.com/s/brXpBSu9l1UKYbvZ6i3HsA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpbWBtxYtD21Zdiaz0sicwf8RMlM2jreQmBUDbTvcFRulwtlR43zYnX6iaXicxoSSh3iawLoRlvws6iaEBkA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Mon, 22 Feb 2021 13:03:59 +0800</pubDate></item><item><title>T for Car-T, G for Gene Therapy</title><link>https://mp.weixin.qq.com/s/1Ewgr7tD7ZEbrsN7GkZtuA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpbePLpg9xedXNYwKNOiaVg7sAavHpibBeTBUtybgDvj96ZxrRLQicSFdC7MDlMhBicy2LfNia4HuicsWVGg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>行家荟萃，助力国内细胞基因治疗技术！]]></content:encoded><pubDate>Mon, 22 Feb 2021 13:03:59 +0800</pubDate></item><item><title>靶点药讯48|纵览全球药物靶点动态</title><link>https://mp.weixin.qq.com/s/aKjgINDukY9lolE0ADmfDQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaPvialoSGNoicdhKRic2uvCMZSC3dALXc759EngibBTiaxCrIoRfPl5gmkIXSE8Movav3qGvvLpEdQ06Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>恒瑞医药、百济神州、基石药业、信达生物......]]></content:encoded><pubDate>Sun, 21 Feb 2021 09:18:42 +0800</pubDate></item><item><title>定了！春天不可错过的细胞治疗权威峰会就在上海！</title><link>https://mp.weixin.qq.com/s/r6kOvQJO0DVTrK35keL6rA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpbePLpg9xedXNYwKNOiaVg7sAavHpibBeTBUtybgDvj96ZxrRLQicSFdC7MDlMhBicy2LfNia4HuicsWVGg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>行家荟萃，助力国内细胞基因治疗技术！]]></content:encoded><pubDate>Sun, 21 Feb 2021 09:18:42 +0800</pubDate></item><item><title>TCR疗法先驱Immunocore喜迎开年红：tebentafusp获突破性疗法认定</title><link>https://mp.weixin.qq.com/s/vWCeqqZcb2mEn_2FiLW3Ew</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpa7zlp4ib2RJX6sGwFDBx3zTwoG0G4CDNlic93sb67smYpEkZj5SfCeUKuYH9vMvs2ng2e1tcRuicWFA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>或将冲出TCR疗法赛道？]]></content:encoded><pubDate>Sat, 20 Feb 2021 11:48:08 +0800</pubDate></item><item><title>国内首个抗ST2抗体临床申报获NMPA受理，来自迈威生物</title><link>https://mp.weixin.qq.com/s/oFxM9wa5rftN9WxxznLulQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpa7zlp4ib2RJX6sGwFDBx3zT9TeJ0VbicBuLuK0atPiahZYLkwEcTTuD6SZyDJYtUx9Jr5vTvaRVbwjg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 20 Feb 2021 11:48:08 +0800</pubDate></item><item><title>首批100万剂科兴中维新冠疫苗克尔来福®运抵香港</title><link>https://mp.weixin.qq.com/s/dj_7yngt7fRjGuBhO1Qfow</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpa7zlp4ib2RJX6sGwFDBx3zTdOhee09QAicg83PrzICcHnajd3jCcEUsMibU49A7XdmEd2icd5hOJnZCw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>香港抗疫里程碑。]]></content:encoded><pubDate>Sat, 20 Feb 2021 11:48:08 +0800</pubDate></item><item><title>春申孟夏，TG-Bio聚焦年度细胞免疫重大突破</title><link>https://mp.weixin.qq.com/s/_6mPTCOa8sUK012nqt5IMA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpbePLpg9xedXNYwKNOiaVg7sAavHpibBeTBUtybgDvj96ZxrRLQicSFdC7MDlMhBicy2LfNia4HuicsWVGg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>行家荟萃，助力国内细胞基因治疗技术！]]></content:encoded><pubDate>Sat, 20 Feb 2021 11:48:08 +0800</pubDate></item><item><title>基因疗法公司能否延续传奇？</title><link>https://mp.weixin.qq.com/s/u-Dr965wVdJPQgmtLXpfcw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYOib4BicibJo48ft3Qumab1sNPEb89Q184BywNyiaiaiazAUzexrdtqZ17R1sBAruKScqiaGcbW50g9vT7A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>基因疗法最终将成为生物技术和制药技术工具箱中一种工具。]]></content:encoded><pubDate>Fri, 19 Feb 2021 12:19:48 +0800</pubDate></item><item><title>安斯泰来首创ADC药物提交两项补充上市申请</title><link>https://mp.weixin.qq.com/s/K4SNmrPum6HmfsQXG67d8g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYOib4BicibJo48ft3Qumab1sNGpxnPR2GNA91qToVXcZ4yCzx7a5fywa2xsjTZMBkLcIkyTRBc0HRuA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Fri, 19 Feb 2021 12:19:48 +0800</pubDate></item><item><title>首款PD-1 vs 鼻咽癌！——君实生物抗PD-1疗法二线治疗鼻咽癌国内上市</title><link>https://mp.weixin.qq.com/s/MQ_cBRyB8fq9kJj282W8pQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYOib4BicibJo48ft3Qumab1sN4kzVT7ib0pKLE3GodB7NpW8HhqxZVZ0aBEXJJ5ibib61RglkYc8Igu8IQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Fri, 19 Feb 2021 12:19:48 +0800</pubDate></item><item><title>《2021版生物制药小编精选汇编》低调现身-我们那么普通，却又那么自信</title><link>https://mp.weixin.qq.com/s/rnHTqwByjNS_WXmN8zFQ6A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpYJvlTDRe08hISahbjxGDoNYlUT6dYdfxscdgSNX3OJC8rr53yM0cT5icNKqa43Q8gITuiakUQMGmicQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>记录最大的意义，是可以不忘记。]]></content:encoded><pubDate>Fri, 19 Feb 2021 12:19:48 +0800</pubDate></item><item><title>又是病毒载体惹的祸，蓝鸟基因疗法LentiGlobin出现插入致癌，Zynteglo被暂停销售</title><link>https://mp.weixin.qq.com/s/rDumilvUP_4FAUv7Dgm_FA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaPvialoSGNoicdhKRic2uvCMZojfiaP3l9pV2xK9KaELPQbSnicfMaIrjDKLgiaT10NUB5BU0qwItlnU0Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Thu, 18 Feb 2021 12:19:31 +0800</pubDate></item><item><title>持续推进基因疗法可及性，诺华与盖茨基金会达成合作</title><link>https://mp.weixin.qq.com/s/Qz68RamsXh2QI-hTvizulA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaPvialoSGNoicdhKRic2uvCMZl4JedFMkGUtDc1Q19Ue4VyaMWC6eibw0syjnPs6RanDeCjINVUx6bfQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Thu, 18 Feb 2021 12:19:31 +0800</pubDate></item><item><title>君实生物XPO1抑制剂JS110获得药物临床试验申请受理通知书</title><link>https://mp.weixin.qq.com/s/HmO8Q-vbykC93v9qf2oTOA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaPvialoSGNoicdhKRic2uvCMZbHudpHq1fNsqOibPj1iacDvVg1VCcI3FIYmIZHLydnpMVDvIDYsg8QKw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>一超多强]]></content:encoded><pubDate>Thu, 18 Feb 2021 12:19:31 +0800</pubDate></item><item><title>百济神州超1亿美元引进BITT创新药物，并参与投资400万美元</title><link>https://mp.weixin.qq.com/s/67w7pQAPd8AdaE6bd71xWQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaPvialoSGNoicdhKRic2uvCMZbHudpHq1fNsqOibPj1iacDvVg1VCcI3FIYmIZHLydnpMVDvIDYsg8QKw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>值得注意的是，百济神州还同时参与了BITT的A轮优先股融资，为其投资400万美元。]]></content:encoded><pubDate>Thu, 18 Feb 2021 12:19:31 +0800</pubDate></item><item><title>百济神州：百悦泽针对WM患者的新适应症上市申请已获FDA受理</title><link>https://mp.weixin.qq.com/s/qGSoOSZ5yv0BSgpsp0SyDw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaPvialoSGNoicdhKRic2uvCMZbHudpHq1fNsqOibPj1iacDvVg1VCcI3FIYmIZHLydnpMVDvIDYsg8QKw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>44.54亿美元]]></content:encoded><pubDate>Thu, 18 Feb 2021 12:19:31 +0800</pubDate></item><item><title>香港给予科兴生物的疫苗紧急使用授权，距专家建议仅两天</title><link>https://mp.weixin.qq.com/s/ZwaDmxa_uxHd-u7R6lBqOw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/qygMQht6xpaPvialoSGNoicdhKRic2uvCMZbHudpHq1fNsqOibPj1iacDvVg1VCcI3FIYmIZHLydnpMVDvIDYsg8QKw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>香港给予科兴生物的疫苗紧急使用授权。]]></content:encoded><pubDate>Thu, 18 Feb 2021 12:19:31 +0800</pubDate></item></channel></rss>